Click to visit the AGGRASTAT website



AGGRASTAT
AGGRASTAT, a cardiovascular product, is FDA approved and is currently being sold by Medicure in the United States.

AVASTREM
Medicure is currently enrolling patients in a phase II clinical trial. AVASTREMTM is being tested for unmet needs in the neurological field.

LICENSING OPPORTUNITIES
Medicure is seeking a partner with an established cardiovascular franchise to support ongoing worldwide clinical antithrombotic development programs.




June 25th, 2009
MEDICURE ANNOUNCES PRIVATE PLACEMENT

April 14th, 2009
MEDICURE ANNOUNCES THIRD QUARTER FISCAL 2009 FINANCIAL RESULTS

March 11th, 2009
MEDICURE ANNOUNCES REGULATORY APPROVAL OF A PHASE II CLINICAL TRIAL OF AVASTREAM FOR THE TREATMENT OF TARDIVE DYSKINESIA

January 13, 2009
MEDICURE ANNOUNCES SECOND QUARTER FISCAL 2009 FINANCIAL RESULTS

  
legal privacy